Twist Bioscience and LenioBio announced a partnership aimed at accelerating AI-guided protein design using real-world protein molecules. The collaboration focuses on enabling rapid data generation from protein candidates to support downstream antibody and drug design cycles. The deal adds another layer to the “data flywheel” model in protein engineering: generating high-quality experimental outputs that can feed machine learning systems and reduce the iteration time between design hypotheses and assay-confirmed performance. For biotech platform vendors and developers, the pairing signals continued investment in improving the practical throughput of AI-assisted protein discovery, particularly where assay scalability can constrain model training and validation.